Skip to content
StockMarketAgent
Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

SHE/301126 stock hub

SHE/301126 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/301126is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.5B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/301126
In the news

Latest news · SHE/301126

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/En/a
P25 23.5P50 41.3P75 83.2
ROE-13.2
P25 -0.9P50 4.1P75 8.8
ROIC2.3
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/301126 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
193
Groups with data
11
Currency
CNY
Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
4,887
Employees Change
1,426%
Employees Change Percent
41.2
Enterprise value
CNY 5.7B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Pharmaceutical Retailers
Isin
CNE1000054V3
Last refreshed
2026-05-10
Market cap
CNY 2.5B
Price
CNY 12.1
Price currency
CNY
Rev Per Employee
1,069,903.39x
Sector
Healthcare
Sic
5122
Symbol
she/301126
Website
https://www.djwk.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
-9.64%
EV Earnings
-23.91x
EV/EBIT
52.56x
EV/EBITDA
34.56x
EV/FCF
-52.49x
EV/Sales
1.1x
FCF yield
-4.39%
P/B ratio
1.55x
P/S ratio
0.48x
PE Ratio3 Y
91.41x
PE Ratio5 Y
77.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
2.08%
EBITDA Margin
2.87%
Gross margin
18.17%
Gross Profit
CNY 950.1M
Gross Profit Growth
-6.72%
Gross Profit Growth Q
6.1%
Gross Profit Growth3 Y
28.85%
Gross Profit Growth5 Y
27.58%
Net Income
CNY -239.6M
Net Income Growth Q
89.7%
Pretax Margin
-4.2%
Profit Margin
-4.58%
Profit Per Employee
CNY -49,036
ROA
1.06
Roa5y
1.99
ROCE
4.62
ROE
-13.24
Roe5y
-0.03
ROIC
2.32
Roic5y
3.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
16.2%
Cagr3y
-4.39%
EPS Growth Q
50
Revenue Growth
-0.46x
Revenue Growth Q
6.49x
Revenue Growth3 Y
13.87x
Revenue Growth5 Y
16.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
CNY 0.81
Assets
CNY 6.4B
Cash
CNY 529.9M
Current Assets
CNY 4.1B
Current Liabilities
CNY 4B
Debt
CNY 3.7B
Debt EBITDA
CNY 22.11
Debt Equity
CNY 2.29
Debt FCF
CNY -33.57
Equity
CNY 1.6B
Liabilities
CNY 4.8B
Long Term Assets
CNY 2.3B
Long Term Liabilities
CNY 757.2M
Net Cash
CNY -3.1B
Net Cash By Market Cap
CNY -126
Net Debt EBITDA
CNY 20.86
Net Debt Equity
CNY 1.96
Tangible Book Value
CNY 294.6M
Tangible Book Value Per Share
CNY 1.48
WACC
3.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.01
Inventory Turnover
4.86
Net Working Capital
CNY 2.4B
Quick ratio
0.73
Working Capital
CNY 45.2M
Working Capital Turnover
CNY 12.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-13.78%
Dividend Growth
0%
Dividend Growth Years
2%
Dividend per share
CNY 0.04
Dividend Years
4
Dividend Yield
0.36%
Ex Div Date
2025-12-15
Last Dividend
CNY 0.02
Payout Frequency
Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
16.19%
200-day SMA
12.27
3Y total return
-12.6%
50-day SMA
11.71
50-day SMA vs 200-day SMA
50under200
All Time High
36.84
All Time High Change
-67.16%
All Time High Date
2022-03-08
All Time Low
6.61
All Time Low Change
83.06%
All Time Low Date
2024-02-08
ATR
0.35
Beta
0.71
Beta1y
0.23
Beta2y
0.38
Ch YTD
-1.55
High
12.15
High52
14.9
High52 Date
2025-08-01
High52ch
-18.79%
Low
11.91
Low52
10.11
Low52 Date
2025-06-23
Low52ch
19.68%
Ma50ch
3.34%
Price vs 200-day SMA
-1.39%
RSI
60.78
RSI Monthly
49.57
RSI Weekly
50.55
Sharpe ratio
0.5x
Sortino ratio
0.91
Total Return
-13.41%
Tr YTD
-1.55
Tr1m
5.95%
Tr1w
0.58%
Tr3m
-2.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 109M
Operating Income Growth
-46.24
Operating Income Growth Q
25.86
Operating Income Growth3 Y
-2.5
Operating Income Growth5 Y
-5.06
Operating margin
2.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
107,760,825%
Net Borrowing
120,888,961
Shares Insiders
42.77%
Shares Institutions
8.58%
Shares Out
205,403,200
Shares Qo Q
-5.41%
Shares Yo Y
13.78%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Adjusted FCF
CNY -109.2M
Average Volume
4,033,929.75x
Bv Per Share
7.51
CAPEX
CNY -93.5M
Ch1m
5.95
Ch1w
0.58
Ch1y
15.13
Ch3m
-2.26
Ch3y
-13.94
Ch6m
-1.87
Change
1.77%
Change From Open
1.6
Close
11.89
Days Gap
0.17
Depreciation Amortization
41,255,565
Dollar Volume
43,344,535.3
Earnings Date
2026-04-28
EBIT
CNY 109M
EBITDA
CNY 150.3M
EPS
CNY -1.11
F Score
3
FCF
CNY -109.2M
FCF EV Yield
-1.91x
FCF Per Share
CNY -0.53
Financing CF
-4,607,573
Fiscal Year End
December
Founded
2,002
Goodwill
1,088,561,611
Income Tax
CNY 9.3M
Investing CF
-160,060,917
Is Primary Listing
1
Last Earnings Date
2026-04-28
Last Report Date
2026-03-31
Ma150
12.25
Ma150ch
-1.25%
Ma20
11.48
Ma20ch
5.45%
Net CF
-180,374,607
Next Earnings Date
2026-09-03
Open
11.91
Payment Date
2025-12-15
Position In Range
79.17
Ppne
952,897,890
Price Date
2026-05-08
Price EBITDA
CNY 16.54
Ptbv Ratio
8.44
Relative Volume
0.89x
Revenue
5,228,617,863x
Tax By Revenue
0.18x
Tr6m
-1.68%
Volume
3,582,193
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHE/301126 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.4%
$0.04 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
2 consecutive years of growth
Total shareholder yield
-13.4%
Next ex-dividend date: 2025-12-15
Performance

SHE/301126 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+16.2%
S&P 500 1Y: n/a
3Y total return
-12.6%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SHE/301126?

Insider, institutional, and short-interest positioning.

Institutional ownership
+8.6%
Share of float held by funds and institutions
Insider ownership
+42.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+13.8%
Negative means the company is buying back shares.
Technical

SHE/301126 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
60.8
Neutral momentum band
Price vs 200-day MA
-1.4%
50/200-day relationship not available
Beta (5Y)
0.71
Less volatile than the market
Sharpe ratio
0.50
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/301126

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301126 stock rating?

she/301126 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301126 analysis?

The full report lives at /stocks/she/301126/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301126?

The latest report frames she/301126 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301126 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.